Robert Derek Newell Purchases 30,000 Shares of Castlight Health, inc. (CSLT) Stock

Castlight Health, inc. (NYSE:CSLT) President Robert Derek Newell acquired 30,000 shares of Castlight Health, inc. stock in a transaction on Friday, October 27th. The shares were bought at an average price of $3.95 per share, with a total value of $118,500.00. Following the completion of the transaction, the president now directly owns 128,671 shares of the company’s stock, valued at approximately $508,250.45. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Robert Derek Newell also recently made the following trade(s):

  • On Wednesday, November 1st, Robert Derek Newell acquired 30,468 shares of Castlight Health, inc. stock. The shares were bought at an average price of $3.95 per share, with a total value of $120,348.60.

Shares of Castlight Health, inc. (NYSE CSLT) opened at $3.95 on Monday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.94 and a current ratio of 1.94. Castlight Health, inc. has a 12-month low of $3.05 and a 12-month high of $5.50.

Castlight Health, inc. (NYSE:CSLT) last issued its earnings results on Wednesday, October 25th. The software maker reported ($0.05) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.07) by $0.02. Castlight Health, inc. had a negative net margin of 45.14% and a negative return on equity of 32.57%. The business had revenue of $34.60 million during the quarter, compared to analysts’ expectations of $34.61 million. During the same period in the prior year, the business earned ($0.05) earnings per share. The company’s quarterly revenue was up 35.7% compared to the same quarter last year. sell-side analysts forecast that Castlight Health, inc. will post -0.44 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Robert Derek Newell Purchases 30,000 Shares of Castlight Health, inc. (CSLT) Stock” was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://ledgergazette.com/2017/11/13/robert-derek-newell-buys-30000-shares-of-castlight-health-inc-cslt-stock.html.

Several institutional investors and hedge funds have recently made changes to their positions in the stock. FMR LLC grew its holdings in shares of Castlight Health, inc. by 49.2% in the second quarter. FMR LLC now owns 11,433,928 shares of the software maker’s stock valued at $47,451,000 after purchasing an additional 3,768,009 shares during the period. Vanguard Group Inc. grew its holdings in shares of Castlight Health, inc. by 36.0% in the second quarter. Vanguard Group Inc. now owns 3,636,948 shares of the software maker’s stock valued at $15,094,000 after purchasing an additional 963,188 shares during the period. Prudential PLC grew its holdings in shares of Castlight Health, inc. by 23.5% in the second quarter. Prudential PLC now owns 2,002,706 shares of the software maker’s stock valued at $8,311,000 after purchasing an additional 380,920 shares during the period. Maverick Capital Ltd. grew its holdings in shares of Castlight Health, inc. by 2.8% in the second quarter. Maverick Capital Ltd. now owns 1,221,809 shares of the software maker’s stock valued at $5,071,000 after purchasing an additional 33,735 shares during the period. Finally, General Electric Co. purchased a new stake in shares of Castlight Health, inc. in the second quarter valued at about $4,338,000. 41.00% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts have weighed in on the stock. BidaskClub cut shares of Castlight Health, inc. from a “sell” rating to a “strong sell” rating in a research report on Thursday. Zacks Investment Research upgraded shares of Castlight Health, inc. from a “hold” rating to a “buy” rating and set a $4.50 price objective for the company in a research report on Monday, October 30th. Canaccord Genuity restated a “buy” rating and set a $7.00 price objective on shares of Castlight Health, inc. in a research report on Thursday, October 26th. Chardan Capital reduced their target price on shares of Castlight Health, inc. from $6.50 to $6.30 and set a “buy” rating for the company in a research report on Thursday, October 26th. Finally, Cantor Fitzgerald reiterated a “hold” rating and issued a $5.00 target price on shares of Castlight Health, inc. in a research report on Wednesday, October 25th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $5.22.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Insider Buying and Selling by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply